Evidence map›Paper›PMID 37283548›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2023

Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.

Kei Yamamoto, Takao Sato, Hanan Salem, Mitsuaki Matsumura, Khady N Fall, Megha Prasad, Vivian G Ng, Sanjum S Sethi, Tamim M Nazif, Sahil A Parikh and 11 more

Open access · greenAbstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Ostial right coronary artery lesions: what to know and how to overcome.Cardiovascular intervention and therapeutics · 2026
    Review
  3. Excessive Ostial Stent Protrusion: Evaluation of Management Strategies and Clinical Outcomes of the Side Flap Technique.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  11. Management of Stent Underexpansion and Aorto-ostial Lesions.Interventional cardiology (London, England) · 2024
    Review
  12. The everolimus eluting Synergy MegatronCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Kei YamamotoDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Takao SatoDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Hanan SalemDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Mitsuaki MatsumuraClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Khady N FallDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Megha PrasadDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Vivian G NgDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Sanjum S SethiDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Tamim M NazifDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Sahil A ParikhDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Torsten P VahlDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Ziad A AliClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Dimitri KarmpaliotisClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
LeRoy E RabbaniDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Michael B CollinsDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Martin B LeonDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Margaret B McEntegartDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Jeffery W MosesDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Ajay J KirtaneDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Gary S MintzClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Akiko MaeharaDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Columbia University Irving Medical Center · USCardiovascular Research Foundation · USSt. Francis Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood.

aimsWe aimed to clarify the cause of ostial RCA ISR using intravascular ultrasound (IVUS).

methodsOverall, 139 ostial RCA ISR lesions were identified with IVUS, pre-revascularisation. Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoatherosclerosis; 3) ostium not covered by the stent; 4) stent fracture or deformation; 5) stent underexpansion (old minimum stent area <4.0 mm

resultsThe median duration from prior stenting was 1.2 (first quartile 0.6, third quartile 3.1) years. The primary mechanisms of ISR were NIH in 25% (n=35) of lesions, neoatherosclerosis in 22% (n=30), uncovered ostium in 6% (n=9) (biological cause 53%, n=74), stent fracture or deformation in 25% (n=35), underexpansion in 11% (n=15), and protruding calcified nodules in 11% (n=15) (mechanical cause 47%, n=65). Including secondary mechanisms, 51% (n=71) of ostial RCA ISRs had stent fractures that were associated with greater hinge motion of the ostial-aorta angle during the cardiac cycle. The Kaplan-Meier rate of target lesion failure at 1 year was 11.5%. When the mechanically caused ISRs were treated without new stents, they suffered a higher subsequent event rate (41.4%) compared with non-mechanical causes or mechanical causes treated without restenting (7.8%, unadjusted hazard ratio 6.44, 95% confidence interval: 2.33-17.78; p<0.0001).

conclusionsHalf of the ostial RCA ISRs were due to mechanical causes. Subsequent event rates were high, especially in mechanically caused ISRs treated without the implantation of a new stent.

Indexed as

Coronary RestenosisCoronary AngiographyCoronary VesselsHumansStentsTreatment Outcome

Identifiers

PMID37283548
PMCPMC10397676
OpenAlexW4379600857

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.